Eisai Co.,Ltd. announced that the Phase Ⅲ SELECT trial of lenvatinib,that was conducted by Eisai with the SFJ Pharmaceuticals Group, a company in investment portfolio of FINTECH GIMV FUND,L.P., meets primary endpoint of progression free survival benefit in treatment of radioiodine-refractory differentiated thyroid cancer.,a company in investment portfolio of FINTECH GIMV FUND,L.P.,announced Bristol-Myers Squibb Company(NYSE:BMY) has acquired iperian,Inc.
Trius Therapeutics ,a company in investment portfolio of FINTECH GIMV FUND,L.P. and Cubist Pharmaceuticals,Inc. announced that they have signed an agreement under which Cubist will acquire Trius Therapeutics.
Toranomon Ham K.K., having been granted the exclusive sales license in Japan in various business areas using the HoneyBaked brand by The Original HoneyBaked Ham Company, which owns one of America's favorite ham brands, will be commencing its operation.
We’ve added Toranomon Ham K.K. to the investment portfolio of FGI